Merck & Co. Inc. (MRK) |
|
85.06 0.57 (0.67%)
|
06-19 14:07 |
|
Open: |
84.25 |
Pre. Close: |
84.49 |
|
High:
|
85.15 |
Low:
|
84.23 |
|
Volume:
|
4,131,733 |
Market Cap:
|
218999M |
|
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
84.749 - 85.075 |
85.075 - 85.449 |
|
Low:
|
82.337 - 82.689 |
82.689 - 83.094 |
|
Close:
|
83.831 - 84.4 |
84.4 - 85.054 |
|
Technical analysis |
as of: 2019-06-19 1:28:29 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 99.46  One year: 116.16 |
| Support: |
Support1: 79.99 Support2: 76.80 |
| Resistance: |
Resistance1: 85.15 Resistance2: 99.46 |
| Pivot: |
82.21 |
| Moving Average: |
MA(5): 83.62 MA(20): 81.79
MA(100): 79.71 MA(250): 74.15 |
| MACD: |
MACD(12,26): 1.30 Signal(9): 1.05 |
| Stochastic oscillator: |
%K(14,3): 90.45 %D(3): 83.82 |
| RSI: |
RSI(14): 70.49 |
| 52-week: |
High: 85.15 Low: 59.80 Change(%): 38.1 |
| Average Vol(K): |
3-Month: 1012907 10-Days: 815067 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.MRK has closed below upper band by 11.5%. Bollinger Bands are 13.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Tue, 18 Jun 2019 00:29:59 Z
Bayer to Invest 5 Billion Euros in Weedkiller Research
Mon, 17 Jun 2019 23:33:00 Z
J&J's (JNJ) Tremfya Meets Goal in Psoriatic Arthritis Study
Mon, 17 Jun 2019 21:29:43 Z
Novartis (NVS) Announces Promising Data on Tasigna & Hyrimoz
Mon, 17 Jun 2019 16:29:10 Z
Notable ETF Inflow Detected - DGRO, VZ, ABBV, MRK
Sat, 15 Jun 2019 14:07:25 Z
5 Biggest Blockbuster Drugs of the Future
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Drug Manufacturers - Major |
| Shares Out. (M) |
2574.64 |
| Shares Float (M) |
2571.42 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
|
|
Shares Short (K)
|
22306 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
4.340 |
|
EPS Est. Current Year
|
3.870 |
|
EPS Est. Next Year
|
4.160 |
|
EPS Est. Next Quarter
|
0.960 |
|
Forward EPS
|
4.551 |
|
Book Value (p.s.)
|
7.610 |
|
PEG Ratio
|
1.67 |
|
Profit Margin
|
19.47 |
|
Operating Margin
|
25.13 |
|
Return on Assets (ttm)
|
10.4 |
|
Return on Equity (ttm)
|
28.9 |
|
Qtrly Rev. Growth
|
7.8 |
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
296.10 |
|
Operating Cash Flow (M)
|
11100.00 |
|
Levered Free Cash Flow (M)
|
8500.00 |
Stock Valuations |
|
P/E
|
19.50 |
|
P/E Growth Ratio
|
|
|
P/BV
|
11.12 |
|
P/S
|
13312410624.00 |
|
P/CF
|
19.63 |
Dividends & Splits |
|
Dividend
|
2.668 |
|
Dividend Yield
|
0.03 |
|
Dividend Pay Date
|
2019-07-08 |
|
Ex-Dividend Date
|
2019-06-14 |
|
Forward Dividend
|
2.200 |
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
